{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:04:20Z","timestamp":1777439060694,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":989,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.chembiol.2010.08.014","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T09:23:21Z","timestamp":1290763401000},"page":"1189-1200","source":"Crossref","is-referenced-by-count":48,"title":["Identification and Evaluation of Small Molecule Pan-Caspase Inhibitors in Huntington's Disease Models"],"prefix":"10.1016","volume":"17","author":[{"given":"Melissa J.","family":"Leyva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"DeGiacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Holcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Gafni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunsun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy S.","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Ellerby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Ellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2010.08.014_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2010.08.014_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2006.01595.x","article-title":"Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury","volume":"7","author":"Baskin-Bey","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.chembiol.2010.08.014_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0076-6879(95)48007-2","article-title":"Theoretical and practical aspects of proteinase inhibition kinetics","volume":"248","author":"Bieth","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.chembiol.2010.08.014_bib4","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/ja710254m","article-title":"Identification of a new class of nonpeptidic inhibitors of cruzain","volume":"130","author":"Brak","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2010.08.014_bib5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/cbic.200500101","article-title":"1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors","volume":"6","author":"Brik","year":"2005","journal-title":"ChemBioChem"},{"key":"10.1016\/j.chembiol.2010.08.014_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2007.07.028","article-title":"Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in\u00a0vivo","volume":"29","author":"Charvin","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.chembiol.2010.08.014_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2010.08.014_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/138161207780163006","article-title":"Inflammatory caspases: targets for novel therapies","volume":"13","author":"Cornelis","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.chembiol.2010.08.014_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2010.08.014_bib10","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2010.08.014_bib11","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII 130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2010.08.014_bib12","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1021\/jm0601405","article-title":"Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10","volume":"49","author":"Ekici","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib13","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.chembiol.2010.08.014_bib14","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.chembiol.2010.08.014_bib15","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib16","doi-asserted-by":"crossref","first-page":"17102","DOI":"10.1074\/jbc.273.27.17102","article-title":"Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide","volume":"273","author":"Gervais","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0092-8674(00)80748-5","article-title":"Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation","volume":"97","author":"Gervais","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2010.08.014_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","article-title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract","volume":"13","author":"Goldberg","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2010.08.014_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2010.08.014_bib20","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.chembiol.2010.08.014_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2010.08.014_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","article-title":"Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease","volume":"11","author":"Hermel","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.chembiol.2010.08.014_bib23","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1021\/jm070111+","article-title":"Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode","volume":"50","author":"Inagaki","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib49","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1087057110373392","article-title":"Composite primary neuronal high-content screening assay for Huntington's disease incorporating non-cell-autonomous interactions","volume":"15","author":"Kaltenbach","year":"2010","journal-title":"Biomol. Screen"},{"key":"10.1016\/j.chembiol.2010.08.014_bib24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.chembiol.2010.08.014_bib25","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.bmcl.2003.12.106","article-title":"Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke","volume":"14","author":"Linton","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2010.08.014_bib26","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1021\/jm050307e","article-title":"First-in-class pan caspase inhibitor developed for the treatment of liver disease","volume":"48","author":"Linton","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2010.08.014_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates","volume":"18","author":"Martindale","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2010.08.014_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1389557043487448","article-title":"Prospects for caspase inhibitors","volume":"4","author":"O'Brien","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib30","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1021\/jm060701s","article-title":"Identification of selective, nonpeptidic nitrile inhibitors of cathepsin S using the substrate activity screening method","volume":"49","author":"Patterson","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib31","doi-asserted-by":"crossref","first-page":"21777","DOI":"10.1074\/jbc.R800084200","article-title":"Human caspases: activation, specificity, and regulation","volume":"284","author":"Pop","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd726","article-title":"Apoptosis-based therapies","volume":"1","author":"Reed","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2010.08.014_bib33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.cdd.4401247","article-title":"Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity","volume":"10","author":"Rozman-Pungercar","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.chembiol.2010.08.014_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.neures.2007.01.002","article-title":"Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice","volume":"57","author":"Sawada","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.chembiol.2010.08.014_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.cdd.4400420","article-title":"Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia","volume":"5","author":"Schulz","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.chembiol.2010.08.014_bib36","doi-asserted-by":"crossref","first-page":"42441","DOI":"10.1074\/jbc.M304895200","article-title":"Crystal structure of xaspase-2, apical initiator of the intrinsic apoptotic pathway","volume":"278","author":"Schweizer","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bmcl.2006.10.100","article-title":"Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)\/legumain","volume":"17","author":"Sexton","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2010.08.014_bib38","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.chembiol.2010.08.014_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/meth.1999.0745","article-title":"Caspases: preparation and characterization","volume":"17","author":"Stennicke","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.chembiol.2010.08.014_bib40","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1074\/jbc.272.15.9677","article-title":"Substrate specificities of caspase family proteases","volume":"272","author":"Talanian","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib41","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.272.29.17907","article-title":"A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis","volume":"272","author":"Thornberry","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bjp.0705662","article-title":"Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease","volume":"141","author":"Toulmond","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2010.08.014_bib43","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2010.08.014_bib44","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1074\/jbc.273.15.9158","article-title":"Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract","volume":"273","author":"Wellington","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib45","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","article-title":"Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells","volume":"275","author":"Wellington","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2010.08.014_bib46","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.chembiol.2010.08.014_bib47","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1021\/ja0547230","article-title":"Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors","volume":"127","author":"Wood","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2010.08.014_bib48","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of Huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1016\/j.chembiol.2013.05.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T00:00:00Z","timestamp":1369267200000}}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552110003996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074552110003996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T17:44:16Z","timestamp":1635961456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074552110003996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1074552110003996"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2010.08.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.chembiol.2013.05.003","asserted-by":"object"}]},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}